JP2007512377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512377A5 JP2007512377A5 JP2006541731A JP2006541731A JP2007512377A5 JP 2007512377 A5 JP2007512377 A5 JP 2007512377A5 JP 2006541731 A JP2006541731 A JP 2006541731A JP 2006541731 A JP2006541731 A JP 2006541731A JP 2007512377 A5 JP2007512377 A5 JP 2007512377A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- matrix
- vector
- expression cassette
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52499303P | 2003-11-24 | 2003-11-24 | |
| US60/524,993 | 2003-11-24 | ||
| PCT/US2004/039633 WO2005051971A1 (en) | 2003-11-24 | 2004-11-23 | Reduction of dermal scarring |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011160099A Division JP2011207912A (ja) | 2003-11-24 | 2011-07-21 | 皮膚瘢痕の縮小 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007512377A JP2007512377A (ja) | 2007-05-17 |
| JP2007512377A5 true JP2007512377A5 (https=) | 2007-12-27 |
| JP4842139B2 JP4842139B2 (ja) | 2011-12-21 |
Family
ID=34632948
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541731A Expired - Fee Related JP4842139B2 (ja) | 2003-11-24 | 2004-11-23 | 皮膚瘢痕の縮小 |
| JP2011160099A Withdrawn JP2011207912A (ja) | 2003-11-24 | 2011-07-21 | 皮膚瘢痕の縮小 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011160099A Withdrawn JP2011207912A (ja) | 2003-11-24 | 2011-07-21 | 皮膚瘢痕の縮小 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7465442B2 (https=) |
| EP (1) | EP1692154A4 (https=) |
| JP (2) | JP4842139B2 (https=) |
| KR (1) | KR101167330B1 (https=) |
| CN (2) | CN101507822B (https=) |
| AU (1) | AU2004293474B2 (https=) |
| BR (1) | BRPI0416920A (https=) |
| CA (1) | CA2546287C (https=) |
| IL (1) | IL175603A (https=) |
| NO (1) | NO20062978L (https=) |
| NZ (1) | NZ546983A (https=) |
| WO (1) | WO2005051971A1 (https=) |
| ZA (1) | ZA200604147B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101507822B (zh) * | 2003-11-24 | 2012-06-06 | 坎吉有限公司 | 皮肤瘢痕形成的减少 |
| US8287538B2 (en) | 2008-01-14 | 2012-10-16 | Conventus Orthopaedics, Inc. | Apparatus and methods for fracture repair |
| EP2342340A1 (en) | 2008-09-22 | 2011-07-13 | Rxi Pharmaceuticals Corporation | Rna interference in skin indications |
| WO2011088172A1 (en) | 2010-01-15 | 2011-07-21 | Brenzel Michael P | Rotary-rigid orthopaedic rod |
| CA2823873A1 (en) | 2010-01-20 | 2011-07-28 | Conventus Orthopaedics, Inc. | Apparatus and methods for bone access and cavity preparation |
| CA2829193A1 (en) | 2010-03-08 | 2011-09-15 | Conventus Orthopaedics, Inc. | Apparatus and methods for securing a bone implant |
| EP3560503B1 (en) | 2010-03-24 | 2021-11-17 | Phio Pharmaceuticals Corp. | Rna interference in dermal and fibrotic indications |
| CN105960265A (zh) * | 2013-12-04 | 2016-09-21 | 阿克赛医药公司 | 利用经化学修饰的寡核苷酸处理伤口愈合的方法 |
| JP6539652B2 (ja) | 2013-12-12 | 2019-07-03 | コンベンタス オーソピディックス， インコーポレイテッド | 組織変位ツールおよび方法 |
| US10900039B2 (en) | 2014-09-05 | 2021-01-26 | Phio Pharmaceuticals Corp. | Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1 |
| CN109069559A (zh) * | 2016-04-14 | 2018-12-21 | 崔泽尔有限公司 | 病毒载体稳定化 |
| US12544344B2 (en) | 2017-04-19 | 2026-02-10 | Phio Pharmaceuticals Corp. | Topical delivery of nucleic acid compounds |
| US10918426B2 (en) | 2017-07-04 | 2021-02-16 | Conventus Orthopaedics, Inc. | Apparatus and methods for treatment of a bone |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394370A (en) | 1981-09-21 | 1983-07-19 | Jefferies Steven R | Bone graft material for osseous defects and method of making same |
| US4505266A (en) | 1981-10-26 | 1985-03-19 | Massachusetts Institute Of Technology | Method of using a fibrous lattice |
| US4485097A (en) | 1982-05-26 | 1984-11-27 | Massachusetts Institute Of Technology | Bone-equivalent and method for preparation thereof |
| JPH0662679B2 (ja) | 1985-06-21 | 1994-08-17 | 新田ゼラチン株式会社 | 組織親和性コラ−ゲンとその製法 |
| AU8532691A (en) * | 1990-08-01 | 1992-03-02 | Chiron Ophthalmics Inc. | Method for treating corneal endothelial wounds |
| US6372249B1 (en) | 1991-12-16 | 2002-04-16 | Baylor College Of Medicine | Senscent cell-derived inhibitors of DNA synthesis |
| US5302706A (en) | 1991-12-16 | 1994-04-12 | Baylor College Of Medicine | Senescent cell derived inhibitors of DNA synthesis |
| US5596079A (en) | 1991-12-16 | 1997-01-21 | Smith; James R. | Mimetics of senescent cell derived inhibitors of DNA synthesis |
| PT665886E (pt) | 1992-10-16 | 2003-10-31 | Cold Spring Harbor Lab | Rearranjo de complexos de ciclina e suas utilizacoes |
| US6211334B1 (en) | 1992-10-16 | 2001-04-03 | Cold Spring Harbor | Cell-cycle regulatory proteins, and uses related thereto |
| FR2702152B1 (fr) | 1993-03-03 | 1995-05-24 | Inst Nat Sante Rech Med | Virus recombinants et leur utilisation en thérapie génique. |
| EP0723402B1 (en) | 1993-08-30 | 2010-08-18 | Baylor College Of Medicine | Senescent cell-derived inhibitors of dna synthesis |
| US6210939B1 (en) | 1993-10-25 | 2001-04-03 | Canji, Inc. | Recombinant adenoviral vector and methods of use |
| TW442569B (en) | 1993-10-25 | 2001-06-23 | Canji Inc | Recombinant adenoviral vector |
| CA2162150C (en) | 1994-03-18 | 2010-03-30 | Mark H. Skolnick | Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
| ES2233943T3 (es) | 1994-05-24 | 2005-06-16 | Baylor College Of Medicine | Mimeticos de inhibidores de la sintesis de dna derivados de celulas senescentes. |
| US5851806A (en) * | 1994-06-10 | 1998-12-22 | Genvec, Inc. | Complementary adenoviral systems and cell lines |
| US5631156A (en) | 1994-06-21 | 1997-05-20 | The University Of Michigan | DNA encoding and 18 KD CDK6 inhibiting protein |
| CA2235810C (en) | 1994-10-24 | 2010-02-09 | Baylor College Of Medicine | Senescent cell-derived inhibitors of dna synthesis |
| US5827702A (en) | 1994-10-31 | 1998-10-27 | Genentech, Inc. | Ocular gene therapy |
| GB9422175D0 (en) | 1994-11-03 | 1994-12-21 | Univ Dundee | Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof |
| WO1996019244A1 (en) | 1994-12-22 | 1996-06-27 | The University Of North Carolina At Chapel Hill | DNA ENCODING A 20 Kd CDK6 INHIBITING PROTEIN |
| US5837520A (en) | 1995-03-07 | 1998-11-17 | Canji, Inc. | Method of purification of viral vectors |
| US5856094A (en) | 1995-05-12 | 1999-01-05 | The Johns Hopkins University School Of Medicine | Method of detection of neoplastic cells |
| US6027742A (en) | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
| US5756283A (en) | 1995-06-05 | 1998-05-26 | The Trustees Of The University Of Pennsylvania | Method for improved production of recombinant adeno-associated viruses for gene therapy |
| HUP9901908A3 (en) | 1995-07-17 | 2000-02-28 | Univ Texas | P16 expression constructs and their application in cancer therapy |
| GB9519275D0 (en) | 1995-09-21 | 1995-11-22 | Univ Dundee | Substances and their therapeutic use |
| US5863904A (en) | 1995-09-26 | 1999-01-26 | The University Of Michigan | Methods for treating cancers and restenosis with P21 |
| US5837511A (en) * | 1995-10-02 | 1998-11-17 | Cornell Research Foundation, Inc. | Non-group C adenoviral vectors |
| US6001853A (en) * | 1996-01-26 | 1999-12-14 | The United States Of America As Represented By The Department Of Health And Human Services | Hydroxylamine compositions for the prevention or retardation of cataracts |
| EP0954222A4 (en) | 1996-04-10 | 2003-01-15 | Univ Southern California | GENE THERAPY FOR PROLIFERATIVE VITREORETINOPATHY |
| IT1285790B1 (it) * | 1996-09-24 | 1998-06-24 | Angeletti P Ist Richerche Bio | Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o |
| US6274614B1 (en) | 1997-02-11 | 2001-08-14 | Qlt Inc. | Methods, compositions and articles for reducing or preventing the effects of inflammation |
| JPH11205102A (ja) | 1998-01-13 | 1999-07-30 | Mitsubishi Electric Corp | 遅延同期回路 |
| US6489305B1 (en) | 1998-05-08 | 2002-12-03 | Canji, Inc. | Methods and compositions for the treatment of ocular diseases |
| US6395029B1 (en) * | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
| AU6919300A (en) * | 1999-08-20 | 2001-03-19 | University Of Pittsburgh | Methods for in vivo gene delivery to sites of cartilage damage |
| US6579522B1 (en) * | 2000-06-27 | 2003-06-17 | Genvec, Inc. | Replication deficient adenoviral TNF vector |
| US6667173B2 (en) | 2000-12-01 | 2003-12-23 | The Schepens Eye Research Institute | Nucleic acids encoding platelet derived growth factor-alpha receptors |
| CN101507822B (zh) * | 2003-11-24 | 2012-06-06 | 坎吉有限公司 | 皮肤瘢痕形成的减少 |
| WO2006042252A2 (en) * | 2004-10-08 | 2006-04-20 | Potentia Pharmeceuticals, Inc. | Viral complement control proteins for eye disorders |
-
2004
- 2004-11-23 CN CN2009101287188A patent/CN101507822B/zh not_active Expired - Fee Related
- 2004-11-23 JP JP2006541731A patent/JP4842139B2/ja not_active Expired - Fee Related
- 2004-11-23 WO PCT/US2004/039633 patent/WO2005051971A1/en not_active Ceased
- 2004-11-23 EP EP04812200A patent/EP1692154A4/en not_active Withdrawn
- 2004-11-23 KR KR1020067012618A patent/KR101167330B1/ko not_active Expired - Fee Related
- 2004-11-23 CA CA2546287A patent/CA2546287C/en not_active Expired - Fee Related
- 2004-11-23 NZ NZ546983A patent/NZ546983A/en not_active IP Right Cessation
- 2004-11-23 CN CNB2004800406132A patent/CN100482674C/zh not_active Expired - Fee Related
- 2004-11-23 BR BRPI0416920-4A patent/BRPI0416920A/pt active Search and Examination
- 2004-11-23 AU AU2004293474A patent/AU2004293474B2/en not_active Ceased
- 2004-11-23 US US10/997,769 patent/US7465442B2/en not_active Expired - Fee Related
-
2006
- 2006-05-11 IL IL175603A patent/IL175603A/en not_active IP Right Cessation
- 2006-05-23 ZA ZA200604147A patent/ZA200604147B/en unknown
- 2006-06-26 NO NO20062978A patent/NO20062978L/no not_active Application Discontinuation
-
2008
- 2008-11-10 US US12/268,311 patent/US20090142397A1/en not_active Abandoned
-
2011
- 2011-02-09 US US13/023,757 patent/US8329671B2/en not_active Expired - Fee Related
- 2011-07-21 JP JP2011160099A patent/JP2011207912A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Development of an antiswelling hydrogel system incorporating M2-exosomes and photothermal effect for diabetic wound healing | |
| JP2007512377A5 (https=) | ||
| JP7033109B2 (ja) | 創傷治癒の方法 | |
| US7420033B2 (en) | Composition of lactoferrin related peptides and uses thereof | |
| Lee et al. | Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor | |
| CN104884076B (zh) | 利用了hmgb1片段的心肌梗塞的治疗方法 | |
| CN1137723C (zh) | 强化的用于加速伤口愈合的伤口覆盖物和组合物 | |
| EP2234628B1 (en) | Compositions and methods of promoting wound healing | |
| Omata et al. | Enhanced bone regeneration by gelatin–β‐tricalcium phosphate composites enabling controlled release of bFGF | |
| JP2019513689A (ja) | 皮膚の創傷、障害、及び疾患を処置するための組成物及び方法 | |
| HRP20090597T1 (hr) | Muteini čimbenika rasta fibroblasta 21 | |
| JP2009522371A (ja) | ウイルス性肝炎の処置 | |
| WO2018223790A1 (zh) | 一种含铁氧化物/纳米高岭土复合止血剂及其制备方法 | |
| JP2024123220A5 (https=) | ||
| JP2005506275A5 (https=) | ||
| Zhang et al. | A multiple-crosslinked injectable hydrogel for modulating tissue microenvironment and accelerating infected diabetic wound repair | |
| Yang et al. | Antioxidant-enriched autologous biogel promoted diabetic wound healing by remodeling inherent posttraumatic inflammatory patterning and restoring compromised microenvironment homeostasis | |
| WO2007022537A2 (en) | Use of lactoferrin as a chemokine and a chemotactic modulator | |
| JP2008508899A5 (https=) | ||
| CN114984233B (zh) | 一种基于鲵皮肤分泌物的局部给药系统及其应用 | |
| JP2003189887A5 (https=) | ||
| JP2006296896A (ja) | コラーゲン薄膜シート、その製造方法、それを用いた再建方法、および自己組織再生誘導型人工皮膚・粘膜 | |
| JP2022502359A5 (https=) | ||
| CN109793913A (zh) | 包含表皮生长因子的缓释膜敷料 | |
| JP2009517343A5 (https=) |